Literature DB >> 2880724

T11TS, the cell surface molecule binding to the "erythrocyte receptor" of T lymphocytes: cellular distribution, purification to homogeneity and biochemical properties.

T Hünig, R Mitnacht, G Tiefenthaler, C Köhler, M Miyasaka.   

Abstract

T11 target structure (T11TS) is a sheep cell surface glycoprotein that binds to the E receptor of human and sheep T lymphocytes. Here we report that T11TS has a broad tissue distribution, including mature and immature hematopoietic cells, vascular endothelium and smooth muscle. The density of T11TS expression was determined by Scatchard analysis with radiolabeled anti-T11TS monoclonal antibody. Red blood cells bound 10,000, and leukocytes bound 4000 to 23,000 antibody molecules per cell. T11TS was purified to homogeneity by immune-affinity and preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and some of its biochemical properties were determined. T11TS is an acidic (pI 4.5) membrane glycoprotein that binds to concanavalin A. It has 2 or 3 N-glycosidically linked carbohydrate side chains of the mature phenotype, no O-linked sugars, and an apparent mol. mass of 42 kDa (glycosylated) and 32 kDa (deglycosylated). The anti-T11TS monoclonal antibody L180/1, which blocks binding of sheep red blood cells to CD2, recognizes a protein determinant on T11TS. These findings are discussed with respect to the possible function of the CD2-T11TS system as a set of complementary cell interaction molecules involved in T cell activation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2880724     DOI: 10.1002/eji.1830161223

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  Identification and tissue distribution of rabbit leucocyte antigens recognized by monoclonal antibodies.

Authors:  J M Wilkinson; J Galea-Lauri; R A Sellars; C Boniface
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

2.  Restricted expression of CD2 among subsets of sheep thymocytes and T lymphocytes.

Authors:  G W Giegerich; W R Hein; M Miyasaka; G Tiefenthaler; T Hünig
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

3.  T11TS impedes glioma angiogenesis by inhibiting VEGF signaling and pro-survival PI3K/Akt/eNOS pathway with concomitant upregulation of PTEN in brain endothelial cells.

Authors:  Debanjan Bhattacharya; Manoj Kumar Singh; Suhnrita Chaudhuri; Sagar Acharya; Anjan Kumar Basu; Swapna Chaudhuri
Journal:  J Neurooncol       Date:  2013-03-08       Impact factor: 4.130

4.  The T11(3) epitope of the CD2 molecule, sheep erythrocytes, and the alternative T-cell activation pathway.

Authors:  H S Warren; V McPhun; A Bezos; C R Parish
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

5.  Adhesion domain of human T11 (CD2) is encoded by a single exon.

Authors:  N E Richardson; H C Chang; N R Brown; R E Hussey; P H Sayre; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

6.  Phenotypic analysis of cells in bronchoalveolar lavage fluid and peripheral blood of maedi visna-infected sheep.

Authors:  L Luján; I Begara; D D Collie; N J Watt
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

7.  Signal requirements for activation of leukaemic T cells from a chronic lymphocytic leukaemia (T-CLL).

Authors:  M R Zocchi; A Poggi; S Heltai; A Villa; L Inverardi; A Vicari; M G Sabbadini; M Ferrarini
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

8.  The structure of the human CD2 gene and its expression in transgenic mice.

Authors:  G Lang; D Wotton; M J Owen; W A Sewell; M H Brown; D Y Mason; M J Crumpton; D Kioussis
Journal:  EMBO J       Date:  1988-06       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.